Ascendis Pharma
ASND
#1448
Rank
HK$120.48 B
Marketcap
HK$1,950
Share price
0.56%
Change (1 day)
57.58%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Ascendis Pharma CIK: 0001612042
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Ascendis Pharma only files 20-F reports

Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2026-02-11

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2025-02-12

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2024-02-07

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2023-02-16

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2022-03-02

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2021-03-10

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2020-04-03

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2019-04-03

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2018-03-28

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2017-03-22

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2016-04-15

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2015-03-26

Language: English

View Annual Report (20-F)